Study of YK012 in B-cell Acute Lymphoblastic Leukemia | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Study of YK012 in B-cell Acute Lymphoblastic Leukemia	B-cell acute lymphoblastic leukemia, B-cell neoplasm, Burkitt lymphoma, DNA Virus Infections, Epstein-Barr virus infection, Hemic and Lymphatic Diseases, Herpesviridae infectious disease, Infections, Neoplasms by Histologic Type, Tumor Virus Infections, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm, viral infectious disease	Recruiting	Phase 1 / Phase 2	2026-02-06		NCT06580301

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Excyte Biopharma Ltd	7

12 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Affiliated Zhongshan Hospital of Dalian University	Dalian	China	14
Guangdong Provincial People's Hospital	Guangzhou	China	85
Henan Provincial People's Hospital	Zhengzhou	China	45
Shengjing Hospital of China Medical University	Shenyang	China	10
Sun Yat-Sen Memorial Hospital	Guangzhou	China	18
Sun Yat-sen University Cancer Center	Guangzhou	China	61
The Affiliated Hospital of Guizhou Medical University	Guiyang	China	20
The Affiliated Hospital of Xuzhou Medical University	Xuzhou	China	30
The First Affiliated Hospital of Nanchang University	Nanchang	China	109
The first Affiliated Hospital, Zhejiang University School of Medicine	Hangzhou	China	69
The First Hospital of Jilin University	Changchun	China	110
The Second Affiliated Hospital of Kunming Medical University	Kunming	China	2